Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Antioxidants (Basel, Switzerland)|November 11, 2022
Oral Administration of Glutathione Trisulfide Increases Reactive Sulfur Levels in Dorsal Root Ganglion and Ameliorates Paclitaxel-Induced Peripheral Neuropathy in MiceMariko Ezaka, Eizo Marutani, Yusuke Miyazaki, et al.
Neuro-Oncology Advances|February 3, 2025
Immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypesKimia Kardani, Shanawaz M Ghouse, Muzammil Arif Din Abdul Jabbar, et al.
Oncotarget|July 30, 2015
A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomasRoberta L Beauchamp, Marianne F James, Patrick A DeSouza, et al.
Neuro-Oncology|April 13, 2019
Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivoSherif G Ahmed, Ahmed Abdelnabi, Casey A Maguire, et al.
Neuro-Oncology|March 9, 2016
A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virusFares Nigim, Shin-Ichi Esaki, Michael Hood, et al.
Human Gene Therapy|June 15, 2021
The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal AdministrationAdam Beharry, Yi Gong, James C Kim, et al.
Plos One|May 23, 2013
Stochastic model of Tsc1 lesions in mouse brainShilpa Prabhakar, June Goto, Xuan Zhang, et al.
Neuro-Oncology|November 5, 2024
Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1Calixto-Hope G Lucas, Andrea M Gross, Carlos G Romo, et al.
Human Pathology|May 29, 2017
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overviewMarkku M Miettinen, Cristina R Antonescu, Christopher D M Fletcher, et al.
Molecular Therapy. Methods & Clinical Development|September 20, 2019
Long-Term Therapeutic Efficacy of Intravenous AAV-Mediated Hamartin Replacement in Mouse Model of Tuberous Sclerosis Type 1Shilpa Prabhakar, Pike See Cheah, Xuan Zhang, et al.
Pageof 10